Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Myeloma
100%
Hematopoietic SCT
100%
Novel Agents
75%
Hematological Malignancies
50%
Transplantation
50%
Autograft
50%
High-dose Chemotherapy
50%
Quality of Life
25%
Lenalidomide
25%
Disease Stage
25%
Number of Patients
25%
Recurrent Disease
25%
Long-term Survival
25%
Response Rate
25%
Excellent Activity
25%
Bortezomib
25%
Good Strategies
25%
Thalidomide
25%
Autotransplantation
25%
Almost Normal
25%
High-dose Therapy
25%
High-dose Melphalan
25%
Tandem Transplantation
25%
Medicine and Dentistry
Myeloma
100%
Autologous Hematopoietic Stem Cell Transplantation
100%
Drug Megadose
66%
Autograft
66%
High Dose Chemotherapy
66%
Hematologic Malignancy
66%
Recurrent Disease
33%
Long Term Survival
33%
Lenalidomide
33%
Melphalan
33%
Autotransplantation
33%
Bortezomib
33%
Quality of Life
33%
Thalidomide
33%
Diseases
33%
Immunology and Microbiology
Drug Megadose
100%
Autologous Hematopoietic Stem Cell Transplantation
100%
Autograft
50%
Lenalidomide
25%
Long Term Survival
25%
Thalidomide
25%
Autotransplantation
25%